The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase I/II study of the safety, pharmacokinetics, and efficacy of pomalidomide in the treatment of Kaposi sarcoma in individuals with or without HIV.
Mark Niccolo Polizzotto
Research Funding - Celgene
Thomas S. Uldrick
Research Funding - Celgene
Kathleen Wyvill
Research Funding - Celgene
Karen Aleman
Research Funding - Celgene
Irini Sereti
Research Funding - Celgene
Giovanna Tosato
Research Funding - Celgene
Denise Whitby
Research Funding - Celgene
Margaret Bevans
Research Funding - Celgene
Frank Maldarelli
Research Funding - Celgene
William Douglas Figg
Research Funding - Celgene
Seth M. Steinberg
Research Funding - Celgene
Robert Yarchoan
Research Funding - Celgene